{"id":"https://openalex.org/W7127099034","doi":"https://doi.org/10.1158/0008-5472.c.8284918","title":"Data from Characterization of Drug-Tolerant Persister Cells in Triple-Negative Breast Cancer Identifies a Shared Persistence Program across Treatments and Patients","display_name":"Data from Characterization of Drug-Tolerant Persister Cells in Triple-Negative Breast Cancer Identifies a Shared Persistence Program across Treatments and Patients","publication_year":2026,"publication_date":"2026-02-02","ids":{"openalex":"https://openalex.org/W7127099034","doi":"https://doi.org/10.1158/0008-5472.c.8284918"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.8284918","doi":"https://doi.org/10.1158/0008-5472.c.8284918","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.8284918","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/0008-5472.c.8284918","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5124855785","display_name":"L\u00e9a Baudre","orcid":"https://orcid.org/0009-0005-3920-3774","observed_orcids":["https://orcid.org/0009-0005-3920-3774"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L\u00e9a Baudre","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-3920-3774","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124728485","display_name":"Gr\u00e9goire Jouault","orcid":"https://orcid.org/0009-0003-0581-8768","observed_orcids":["https://orcid.org/0009-0003-0581-8768"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gr\u00e9goire Jouault","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-0581-8768","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087832103","display_name":"Pac\u00f4me Prompsy","orcid":"https://orcid.org/0000-0003-4375-7583","observed_orcids":["https://orcid.org/0000-0003-4375-7583"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pac\u00f4me Prompsy","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4375-7583","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050853266","display_name":"M\u00e9lissa Saichi","orcid":"https://orcid.org/0000-0001-6461-1482","observed_orcids":["https://orcid.org/0000-0001-6461-1482"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melissa Saichi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6461-1482","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124706696","display_name":"Sarah Gastineau","orcid":"https://orcid.org/0009-0001-0222-2147","observed_orcids":["https://orcid.org/0009-0001-0222-2147"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sarah Gastineau","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0001-0222-2147","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045322704","display_name":"Christophe Huret","orcid":"https://orcid.org/0009-0003-3082-342X","observed_orcids":["https://orcid.org/0009-0003-3082-342X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christophe Huret","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-3082-342X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046345134","display_name":"Laura Sourd","orcid":"https://orcid.org/0000-0001-6010-7721","observed_orcids":["https://orcid.org/0000-0001-6010-7721"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura Sourd","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6010-7721","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108141884","display_name":"Ahmed Dahmani","orcid":"https://orcid.org/0000-0002-8770-120X","observed_orcids":["https://orcid.org/0000-0002-8770-120X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ahmed Dahmani","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8770-120X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017101736","display_name":"\u00c9lodie Montaudon","orcid":"https://orcid.org/0009-0002-5197-8300","observed_orcids":["https://orcid.org/0009-0002-5197-8300"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elodie Montaudon","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-5197-8300","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055459949","display_name":"Florent Dingli","orcid":"https://orcid.org/0000-0002-7715-2446","observed_orcids":["https://orcid.org/0000-0002-7715-2446"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Florent Dingli","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7715-2446","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005511583","display_name":"Damarys Loew","orcid":"https://orcid.org/0000-0002-9111-8842","observed_orcids":["https://orcid.org/0000-0002-9111-8842"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Damarys Loew","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9111-8842","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059398124","display_name":"Elisabetta Marangoni","orcid":"https://orcid.org/0000-0002-3337-6448","observed_orcids":["https://orcid.org/0000-0002-3337-6448"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elisabetta Marangoni","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3337-6448","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025568011","display_name":"Justine Marsolier","orcid":"https://orcid.org/0000-0001-8464-9306","observed_orcids":["https://orcid.org/0000-0001-8464-9306"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Justine Marsolier","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8464-9306","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5051580508","display_name":"C\u00e9line Vallot","orcid":"https://orcid.org/0000-0003-1601-2359","observed_orcids":["https://orcid.org/0000-0003-1601-2359"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C\u00e9line Vallot","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1601-2359","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.9643999934196472,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.9643999934196472,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.00839999970048666,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11829","display_name":"Mathematical Biology Tumor Growth","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2611","display_name":"Modeling and Simulation"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-tolerant-persister-cells","display_name":"drug-tolerant persister cells","score":0.9959999918937683},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9879999756813049},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.6740000247955322},{"id":"https://openalex.org/keywords/transcriptional-plasticity","display_name":"transcriptional plasticity","score":0.9179999828338623},{"id":"https://openalex.org/keywords/fosl1","display_name":"FOSL1","score":0.8709999918937683},{"id":"https://openalex.org/keywords/ap-1","display_name":"AP-1","score":0.8420000076293945},{"id":"https://openalex.org/keywords/nf-kappab","display_name":"NF-\u03baB","score":0.9710000157356262},{"id":"https://openalex.org/keywords/stress-response","display_name":"stress response","score":0.8870000243186951},{"id":"https://openalex.org/keywords/inflammatory-signaling-pathways","display_name":"inflammatory signaling","score":0.8360000252723694},{"id":"https://openalex.org/keywords/enhancer-binding","display_name":"enhancer binding","score":0.777999997138977},{"id":"https://openalex.org/keywords/gene-regulatory-networks","display_name":"gene regulatory networks","score":0.8830000162124634},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.8600000143051147},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.9070000052452087},{"id":"https://openalex.org/keywords/targeted-therapy-resistance","display_name":"targeted therapy resistance","score":0.7129999995231628},{"id":"https://openalex.org/keywords/tumor-recurrence","display_name":"tumor recurrence","score":0.550000011920929},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8230000138282776}],"concepts":[{"id":"https://openalex.org/C136622501","wikidata":"https://www.wikidata.org/wiki/Q6934671","display_name":"Multidrug tolerance","level":4,"score":0.8560000061988831},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5995000004768372},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.580299973487854},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4977000057697296},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47279998660087585},{"id":"https://openalex.org/C77255625","wikidata":"https://www.wikidata.org/wiki/Q402093","display_name":"Reprogramming","level":3,"score":0.4505000114440918},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.3944000005722046},{"id":"https://openalex.org/C2778024521","wikidata":"https://www.wikidata.org/wiki/Q55639806","display_name":"Basal (medicine)","level":3,"score":0.3817000091075897},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.3646000027656555},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35740000009536743},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.352400004863739},{"id":"https://openalex.org/C2781009140","wikidata":"https://www.wikidata.org/wiki/Q7170389","display_name":"Persistence (discontinuity)","level":2,"score":0.3393000066280365},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3043999969959259},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.2903999984264374},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.28540000319480896},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.275299996137619},{"id":"https://openalex.org/C58123911","wikidata":"https://www.wikidata.org/wiki/Q467410","display_name":"Biofilm","level":3,"score":0.2703000009059906},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2637999951839447},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.26030001044273376}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.8284918","doi":"https://doi.org/10.1158/0008-5472.c.8284918","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.8284918","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.8284918","doi":"https://doi.org/10.1158/0008-5472.c.8284918","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.8284918","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4415967897","https://openalex.org/W4408610193","https://openalex.org/W7127051767","https://openalex.org/W7127042254","https://openalex.org/W7127046718","https://openalex.org/W7127044106","https://openalex.org/W7127161169","https://openalex.org/W7127118078","https://openalex.org/W7152396510","https://openalex.org/W7127116221"],"abstract_inverted_index":{"Abstract":[0],"Acquisition":[1],"of":[2,15,20,69,72,87,93,117,130,153,175,197,200],"resistance":[3],"to":[4,44,60,113,142,167,186,219],"anticancer":[5],"therapies":[6],"is":[7,26],"a":[8,61,164,184],"multistep":[9],"process":[10],"initiated":[11],"by":[12,146],"the":[13,32,73,127,143,151,157,169,198,201],"survival":[14],"drug-tolerant":[16,21,202],"persister":[17,22,46,74,133,144,170,203],"cells.":[18,155],"Accessibility":[19],"cells":[23,52,110,141,160],"in":[24,56,76,104,111,205],"patients":[25,213],"limited,":[27],"which":[28],"has":[29],"hindered":[30],"understanding":[31],"mechanisms":[33],"driving":[34],"their":[35],"emergence.":[36],"In":[37],"this":[38,131,181],"study,":[39],"using":[40],"multiple":[41,179],"patient-derived":[42],"models":[43],"isolate":[45],"cells,":[47],"we":[48],"showed":[49],"that":[50,192,216],"these":[51],"are":[53],"transcriptionally":[54],"plastic":[55],"vivo":[57],"and":[58,96,107,124,149,214,222],"return":[59],"common":[62],"treatment":[63,82],"na\u00efve\u2013like":[64],"state":[65,75,145,204],"upon":[66],"relapse,":[67],"regardless":[68],"treatment.":[70],"Hallmarks":[71],"triple-negative":[77,206],"breast":[78,106,207],"cancer":[79,109,154,159,208],"(TNBC)":[80],"across":[81,212],"modalities":[83],"included":[84],"high":[85],"expression":[86],"basal":[88],"keratins":[89],"together":[90],"with":[91],"activation":[92],"stress":[94],"response":[95,112],"inflammation":[97],"pathways.":[98],"These":[99],"hallmarks":[100,174],"were":[101],"also":[102],"activated":[103],"HER2+":[105],"lung":[108],"targeted":[114],"therapies.":[115],"Analysis":[116],"gene":[118],"regulatory":[119],"networks":[120],"identified":[121],"AP-1,":[122],"NF-\u03baB,":[123],"IRF/STAT":[125],"as":[126],"key":[128],"drivers":[129],"hallmark":[132],"state.":[134,171],"Functionally,":[135],"FOSL1,":[136],"an":[137],"AP-1":[138],"member,":[139],"drove":[140],"binding":[147],"enhancers":[148],"reprogramming":[150],"transcriptome":[152],"On":[156],"contrary,":[158],"without":[161],"FOSL1":[162],"had":[163],"decreased":[165],"ability":[166],"reach":[168],"By":[172],"defining":[173],"TNBC":[176],"persistence":[177,221],"on":[178],"therapies,":[180],"study":[182],"provides":[183],"resource":[185],"design":[187],"effective":[188],"combination":[189],"therapeutic":[190],"strategies":[191],"limit":[193],"resistance.":[194],"Significance:":[195],"Elucidation":[196],"features":[199],"reveals":[209],"shared":[210],"programs":[211],"treatments":[215],"offer":[217],"opportunities":[218],"prevent":[220],"delay":[223],"tumor":[224],"recurrence.":[225]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-02-03T00:00:00"}